Veriheal

DECEMBER 30, 2020

If you answered yes to these two questions, then the DEA might have the job for you. The DEA is seeking a contractor that has the ability to destroy illegal drugs without leaving detectable levels behind. .” What about the option of donating the confiscated cannabis to a veteran program to be utilized in making RSO?

DEA 52

DEA Pharmaceutical Packaging Business 52

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. MAPS continued to publish Bulletin articles about MDMA research , requests for donations , and discontinuing animal studies. submitted his first DEA application to manufacture marijuana for use in medical research. MAPS Founder Rick Doblin, Ph.D., Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. It’s been nearly three years since the DEA announced its revolutionary cultivator program. The only problem is, the program doesn’t actually exist.

DEA 221

DEA Research and Development Clinical Trials Patients 221